Javara
- 12/04/2022
- Series B
- $30,000,000
#researchreimagined. Experience the future of clinical trials.
- Industry Research Services
- Website https://javararesearch.com/
- LinkedIn https://www.linkedin.com/company/javara/about/
Related People
Jennifer ByrneFounder
Devoted to leading organizations, building teams and partnerships centered on advancing the clinical research enterprise; namely to better connect patients and providers to clinical trials. CEO of Javara, former CEO of PMG Research and Founder of Greater Gift (501(c)3), Jennifer has vast involvement in the clinical research enterprise across collaborations with hundreds of life science organizations, Contract Research Organizations (CROs), technology, healthcare systems, site organizations, CDC, and other research service providers for the direct execution of over 7,500 Phase I-IV clinical trials which have included over 100,000 clinical trial volunteers. A clinical research business leader thriving on building high performing teams and trusted partnerships while navigating the complexities of the evolving healthcare and bio-pharmaceutical challenges and opportunities leading to differentiated and better outcomes for all stakeholders; namely the patient.
Recognized as a CenterWatch Top 20 Innovator and is the recipient of the ACRP’s 2018 Innovation in Clinical Research Award and the NC Biotech of the Piedmont Region Innovator of the Year. She currently serves as Board Chair for Javara Inc, Chair, Greater Gift, Board of Trustee for The Association of Clinical Research Professionals (ACRP) and Advisory Chair for the Wake Forest University Masters in Clinical Research Management. Additionally serving as a Advisory Board member to CISCRP, Wake Forest Institute of Regenerative Medicine, FCA Health Innovations Fund, North Carolina Biotech of the Piedmont Triad and serves on the Leadership Advisory Board for the Avoca Quality Consortium, CRAACO, and the Workforce Innovation Steering Committee for ACRP.